1996-2007: Advancement

Before 1996, an HIV diagnosis left people with few options with no known cure or effective treatment. The introduction of highly active antiretroviral therapy (HAART) was a major breakthrough and gave hope to millions of people living with HIV around the world. Those who had access to HAART saw their life expectancy increase by an average of 15 years – unheard of at the time.

Throughout this period, a number of scientific advancements continued to dramatically improve the lives of people living with HIV and of the communities most affected by the epidemic. Beyond HAART, other treatment advances and the development of viral load monitoring and rapid tests for HIV transformed diagnosis and treatment.

12th International AIDS conference

The International AIDS Conference in Geneva reports on the growth of multi-drug resistant strains of HIV.

First combination pill

The first combination antiretroviral pill, Combivir, is approved in the USA, greatly simplifying HIV treatment.

Vancouver AIDS Conference

The International AIDS Conference in Vancouver highlights new treatment advances.

UNAIDS launched

UNAIDS is launched to advocate for and co-ordinate global efforts on HIV and AIDS.

Nevirapine approved

The first Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) drug, Nevirapine, is approved in the US.

HAART

The era of Highly Active Antiretroviral Treatment (HAART) begins, with immediate and dramatic benefits for those with access.

Pages

Subscribe to RSS - 1996-2007: Advancement